JP6725601B2 - インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 - Google Patents
インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 Download PDFInfo
- Publication number
- JP6725601B2 JP6725601B2 JP2018153634A JP2018153634A JP6725601B2 JP 6725601 B2 JP6725601 B2 JP 6725601B2 JP 2018153634 A JP2018153634 A JP 2018153634A JP 2018153634 A JP2018153634 A JP 2018153634A JP 6725601 B2 JP6725601 B2 JP 6725601B2
- Authority
- JP
- Japan
- Prior art keywords
- leaflet
- valve
- pores
- elastomer
- fluoropolymer
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 239000002131 composite material Substances 0.000 title claims description 57
- 229920000642 polymer Polymers 0.000 title description 27
- 239000007943 implant Substances 0.000 title description 4
- 229920002313 fluoropolymer Polymers 0.000 claims description 78
- 239000004811 fluoropolymer Substances 0.000 claims description 78
- 229920001971 elastomer Polymers 0.000 claims description 56
- 239000000806 elastomer Substances 0.000 claims description 56
- 239000011148 porous material Substances 0.000 claims description 51
- 239000000463 material Substances 0.000 claims description 50
- 210000003709 heart valve Anatomy 0.000 claims description 30
- 230000017531 blood circulation Effects 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 24
- 229920001343 polytetrafluoroethylene Polymers 0.000 claims description 18
- 239000004810 polytetrafluoroethylene Substances 0.000 claims description 18
- 239000013536 elastomeric material Substances 0.000 claims description 15
- 229920001577 copolymer Polymers 0.000 claims description 13
- 239000011159 matrix material Substances 0.000 claims description 11
- BLTXWCKMNMYXEA-UHFFFAOYSA-N 1,1,2-trifluoro-2-(trifluoromethoxy)ethene Chemical compound FC(F)=C(F)OC(F)(F)F BLTXWCKMNMYXEA-UHFFFAOYSA-N 0.000 claims description 6
- BFKJFAAPBSQJPD-UHFFFAOYSA-N tetrafluoroethene Chemical group FC(F)=C(F)F BFKJFAAPBSQJPD-UHFFFAOYSA-N 0.000 claims description 6
- 239000002904 solvent Substances 0.000 claims description 5
- 230000000295 complement effect Effects 0.000 claims description 3
- 229920000295 expanded polytetrafluoroethylene Polymers 0.000 claims description 3
- 239000006185 dispersion Substances 0.000 claims description 2
- 238000001704 evaporation Methods 0.000 claims description 2
- 230000000379 polymerizing effect Effects 0.000 claims description 2
- 206010067171 Regurgitation Diseases 0.000 claims 2
- 230000001276 controlling effect Effects 0.000 claims 2
- 230000032798 delamination Effects 0.000 claims 1
- 230000001105 regulatory effect Effects 0.000 claims 1
- 239000012528 membrane Substances 0.000 description 62
- 238000012360 testing method Methods 0.000 description 19
- 238000005259 measurement Methods 0.000 description 18
- 239000000835 fiber Substances 0.000 description 17
- 229920001973 fluoroelastomer Polymers 0.000 description 17
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 15
- 229920009441 perflouroethylene propylene Polymers 0.000 description 15
- 230000006835 compression Effects 0.000 description 14
- 238000007906 compression Methods 0.000 description 14
- 239000010408 film Substances 0.000 description 13
- 229920001296 polysiloxane Polymers 0.000 description 12
- 230000010349 pulsation Effects 0.000 description 9
- 230000000747 cardiac effect Effects 0.000 description 8
- 229920001169 thermoplastic Polymers 0.000 description 8
- 230000015572 biosynthetic process Effects 0.000 description 7
- 238000000576 coating method Methods 0.000 description 7
- 239000004416 thermosoftening plastic Substances 0.000 description 7
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 239000011248 coating agent Substances 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 230000000712 assembly Effects 0.000 description 4
- 238000000429 assembly Methods 0.000 description 4
- 238000005452 bending Methods 0.000 description 4
- 238000010438 heat treatment Methods 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 238000000465 moulding Methods 0.000 description 4
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 230000008859 change Effects 0.000 description 3
- 230000000052 comparative effect Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 239000013013 elastic material Substances 0.000 description 3
- 239000012530 fluid Substances 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 229910052751 metal Inorganic materials 0.000 description 3
- 239000002184 metal Substances 0.000 description 3
- -1 poly(vinyl acetate) Polymers 0.000 description 3
- 238000001878 scanning electron micrograph Methods 0.000 description 3
- 238000005476 soldering Methods 0.000 description 3
- 230000000007 visual effect Effects 0.000 description 3
- 229910000619 316 stainless steel Inorganic materials 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 229920001410 Microfiber Polymers 0.000 description 2
- 229910000831 Steel Inorganic materials 0.000 description 2
- PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 230000002308 calcification Effects 0.000 description 2
- 229910052791 calcium Inorganic materials 0.000 description 2
- 239000011575 calcium Substances 0.000 description 2
- 238000012512 characterization method Methods 0.000 description 2
- 230000000593 degrading effect Effects 0.000 description 2
- 230000006866 deterioration Effects 0.000 description 2
- 238000009661 fatigue test Methods 0.000 description 2
- 239000001307 helium Substances 0.000 description 2
- 229910052734 helium Inorganic materials 0.000 description 2
- SWQJXJOGLNCZEY-UHFFFAOYSA-N helium atom Chemical compound [He] SWQJXJOGLNCZEY-UHFFFAOYSA-N 0.000 description 2
- 230000000004 hemodynamic effect Effects 0.000 description 2
- 238000002513 implantation Methods 0.000 description 2
- 238000001727 in vivo Methods 0.000 description 2
- 239000003658 microfiber Substances 0.000 description 2
- 238000012986 modification Methods 0.000 description 2
- 230000004048 modification Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 230000002093 peripheral effect Effects 0.000 description 2
- 238000003825 pressing Methods 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 238000001179 sorption measurement Methods 0.000 description 2
- 239000007921 spray Substances 0.000 description 2
- 239000010959 steel Substances 0.000 description 2
- 238000010998 test method Methods 0.000 description 2
- 230000002861 ventricular Effects 0.000 description 2
- 238000009736 wetting Methods 0.000 description 2
- 241001465754 Metazoa Species 0.000 description 1
- 239000004687 Nylon copolymer Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 101100248283 Salmonella paratyphi A (strain ATCC 9150 / SARB42) rhaS gene Proteins 0.000 description 1
- 208000007536 Thrombosis Diseases 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 239000012298 atmosphere Substances 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 239000000560 biocompatible material Substances 0.000 description 1
- 229920000249 biocompatible polymer Polymers 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 230000003205 diastolic effect Effects 0.000 description 1
- 238000006073 displacement reaction Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000000635 electron micrograph Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 238000001125 extrusion Methods 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 238000005187 foaming Methods 0.000 description 1
- 229920001519 homopolymer Polymers 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000010348 incorporation Methods 0.000 description 1
- 239000011256 inorganic filler Substances 0.000 description 1
- 229910003475 inorganic filler Inorganic materials 0.000 description 1
- 238000005304 joining Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000006082 mold release agent Substances 0.000 description 1
- 238000010068 moulding (rubber) Methods 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 238000009832 plasma treatment Methods 0.000 description 1
- 238000005498 polishing Methods 0.000 description 1
- 229920000728 polyester Polymers 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000003252 repetitive effect Effects 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 229920002379 silicone rubber Polymers 0.000 description 1
- 239000004945 silicone rubber Substances 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 230000007480 spreading Effects 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 238000005728 strengthening Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 229940124597 therapeutic agent Drugs 0.000 description 1
- 229920001187 thermosetting polymer Polymers 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- ZSDSQXJSNMTJDA-UHFFFAOYSA-N trifluralin Chemical compound CCCN(CCC)C1=C([N+]([O-])=O)C=C(C(F)(F)F)C=C1[N+]([O-])=O ZSDSQXJSNMTJDA-UHFFFAOYSA-N 0.000 description 1
- 150000003673 urethanes Chemical class 0.000 description 1
- 230000009978 visual deterioration Effects 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2415—Manufacturing methods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
- A61F2/2418—Scaffolds therefor, e.g. support stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2469—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with resilient valve members, e.g. conical spiral
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2472—Devices for testing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/507—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials for artificial blood vessels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2412—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with soft flexible valve members, e.g. tissue valves shaped like natural valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
- A61F2/02—Prostheses implantable into the body
- A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
- A61F2/2475—Venous valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2210/00—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2210/0076—Particular material properties of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof multilayered, e.g. laminated structures
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2220/00—Fixations or connections for prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2220/0025—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements
- A61F2220/005—Connections or couplings between prosthetic parts, e.g. between modular parts; Connecting elements using adhesives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0006—Rounded shapes, e.g. with rounded corners circular
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0004—Rounded shapes, e.g. with rounded corners
- A61F2230/0013—Horseshoe-shaped, e.g. crescent-shaped, C-shaped, U-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2230/00—Geometry of prostheses classified in groups A61F2/00 - A61F2/26 or A61F2/82 or A61F9/00 or A61F11/00 or subgroups thereof
- A61F2230/0002—Two-dimensional shapes, e.g. cross-sections
- A61F2230/0028—Shapes in the form of latin or greek characters
- A61F2230/0054—V-shaped
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2430/00—Materials or treatment for tissue regeneration
- A61L2430/20—Materials or treatment for tissue regeneration for reconstruction of the heart, e.g. heart valves
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/02—Inorganic materials
- A61L27/025—Other specific inorganic materials not covered by A61L27/04 - A61L27/12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Transplantation (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Chemical & Material Sciences (AREA)
- Biomedical Technology (AREA)
- Vascular Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Composite Materials (AREA)
- Materials Engineering (AREA)
- Manufacturing & Machinery (AREA)
- Dispersion Chemistry (AREA)
- Prostheses (AREA)
- Materials For Medical Uses (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Organic Chemistry (AREA)
- Laminated Bodies (AREA)
Description
一実施態様に係る心臓弁リーフレットを、延伸フルオロポリマー膜とエラストマー材料とを含む複合材料から形成し、金属製バルーン拡張型ステントに接合した。その方法を以下に記載する。
堅固な金属製フレームに接合したポリマー製リーフレットを備える心臓弁を以下のようにして構成した。
堅固な金属製フレームに接合したポリマー製リーフレットを有する心臓弁を以下の方法に従って構成した。
エラストマーを組み込まなかった点が除き、実施例1と同様にして、6つの弁を構成した。ePTFE材料は、実施例1に記載したものと同じだったが、フルオロエラストマー・コポリマーを吸収させず、その代わりに熱可塑性接着剤として機能するFEPコポリマーの不連続な層で被覆した。弁は実施例1のようにして構成した。それぞれのリーフレットは、膜からなる3つの層を備え、リーフレットの最終的な厚みの平均は約20μmになった。流体力学的特徴づけの後、弁を実施例1で説明したDynatek加速試験機に取り付けた。サイクルが約4千万回になるまでにリーフレットで縁部の剥離及び穴の形成が観察されたため、試験を停止した。
実施例1と同様にして2つの弁を構成したが、本発明のエラストマー部は組み込まなかった。使用した材料は、以下のような特性を有する薄いePTFE膜であった:単位面積あたりの質量が約2.43g/m2、細孔率が約88%、IBPが約4.8KPa、厚みが約13.8μm、一方向のマトリックス引張強度が約662MPa、直交方向のマトリックス引張強度が約1.2MPa。このePTFE膜を付録に記載した方法に従って試験した。この膜を10層、向きを交互に変えて重ねて配置した後、実施例1に記載したツールの上に配置した。次に、そのツールを対流空気炉の中で約25分間にわたって約350℃に曝した後、取り出し、水浴の中で急冷した。次に、ツールの3つの部品をステント・フレームに挿入し、実施例1のようにFEPを有する弁組立体にリーフレットを接合した。
本明細書では、マトリックス引張強度は、特定の条件下における多孔性フルオロポリマーのサンプルの引張強度を意味する。サンプルの細孔率は、引張強度に、サンプルの密度に対するポリマーの密度の比を掛けることによって求まる。
Claims (29)
- 開放状態と閉鎖状態との間を移動できる複数のリーフレットを備えた人工弁であって、各リーフレットが、複数の細孔を有する少なくとも1つのフルオロポリマー層と、前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべてに存在するエラストマー又はエラストマー材料とを有する複合材料を含み、前記エラストマー又はエラストマー材料がTFE/PMVEコポリマーであることを特徴とする、人工弁。
- 前記複合材料が70重量%未満のフルオロポリマーを含む、請求項1に記載の人工弁。
- 前記複合材料が60重量%未満のフルオロポリマーを含む、請求項1又は2に記載の人工弁。
- 前記複合材料が50重量%未満のフルオロポリマーを含む、請求項1〜3のいずれか1項に記載の人工弁。
- 前記コポリマーが、40〜80重量%のペルフルオロメチルビニルエーテル及びそれと相補的な60〜20重量%のテトラフルオロエチレンを含んでなる、請求項1に記載の人工弁。
- 前記フルオロポリマーがPTFEである、請求項1〜5のいずれか1項に記載の人工弁。
- 前記PTFEがePTFEである、請求項6に記載の人工弁。
- 前記少なくとも1つのフルオロポリマー層が、少なくとも1つの方向において96MPaよりも大きいマトリックス引張強度を有する、請求項1〜7のいずれか1項に記載の人工弁。
- 前記リーフレットの厚みが350μm未満である、請求項1〜8のいずれか1項に記載の人工弁。
- 前記リーフレットの厚みが300μm未満である、請求項1〜9のいずれか1項に記載の人工弁。
- 前記リーフレットの厚みが200μm未満である、請求項1〜10のいずれか1項に記載の人工弁。
- 前記リーフレットの厚みが100μm未満である、請求項1〜11のいずれか1項に記載の人工弁。
- 前記リーフレットの厚みが50μm未満である、請求項1〜12のいずれか1項に記載の人工弁。
- 前記リーフレットの厚みが25μm未満である、請求項1〜13のいずれか1項に記載の人工弁。
- 血流方向を調節するための前記人工弁を横断するEOAが、4千万回のサイクルの後、10%以内に維持される、請求項1〜14のいずれか1項に記載の人工弁。
- 血流方向を調節するための前記人工弁を横断する逆流率が、4千万回のサイクルの後、15%未満に維持される、請求項1〜15のいずれか1項に記載の人工弁。
- 4千万回のサイクルの後、前記リーフレットに端部剥離又は孔形成が生じない、請求項1〜16のいずれか1項に記載の人工弁。
- 請求項1〜17のいずれか1項に記載の人工弁の複合材料を形成する方法であって、
(a)前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべてを満たすための溶液の調製に適した溶媒に、エラストマー又はエラストマー材料を溶かすステップ、
(b)前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべてを満たすステップ、及び
(c)前記溶媒を蒸発させて、前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべての中に前記エラストマー又はエラストマー材料を残存させるステップ
を含み、前記エラストマー又はエラストマー材料がTFE/PMVEコポリマーである、前記方法。 - 請求項18に記載の方法であって、前記ステップ(b)が、前記エラストマー又はエラストマー材料を、分散液によって、前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべてに供給するステップを含む、前記方法。
- 請求項18又は19に記載の方法であって、前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべてにおいて前記エラストマー又はエラストマー材料を重合させるステップをさらに含む、前記方法。
- 支持構造と、
開放状態と閉鎖状態との間を移動して人工弁を通過する血流を調節することができる、前記支持構造に支持されたリーフレットと、
前記支持構造の少なくとも一部と前記リーフレットの少なくとも一部との間に位置するクッション部材と
を備えた、人工弁であって、
前記クッション部材が、複合材料から形成され、前記複合材料が、少なくとも1つのフルオロポリマー層を有し、前記フルオロポリマー層が、複数の細孔と前記細孔の実質的にすべてに存在するエラストマー又はエラストマー材料とを有し、前記エラストマー又はエラストマー材料がTFE/PMVEコポリマーであることを特徴とする、前記人工弁。 - 前記支持構造が長手方向に延びる柱を備えており、前記リーフレットの一部が前記柱のまわりに巻き付けられることによって、前記リーフレットが前記支持構造に固定されている、請求項21に記載の人工弁。
- 前記クッション部材の前記少なくとも1つのフルオロポリマー層が、多孔性ePTFEで形成されている、請求項21又は22に記載の人工弁。
- 長手方向に延びる柱を有する第1の端部、及びその反対側の第2の端部を有するほぼ環状の支持構造と、
前記支持構造の外周に沿って延びているとともに、それぞれ前記柱の反対側に沿って延びる第1及び第2のリーフレットを形成しているリーフレット材料のシートと、
前記柱に接続されることによって前記柱と前記第1及び第2のリーフレットとの間にクッションを実現するクッション部材と
を備えた、人工弁であって、
各リーフレットが、複合材料を含み、前記複合材料が、複数の細孔を有する少なくとも1つのフルオロポリマー層と、前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべてに存在するエラストマー又はエラストマー材料とを有し、前記エラストマー又はエラストマー材料がTFE/PMVEコポリマーであることを特徴とする、人工弁。 - ヒト患者の血流方向を調節するための人工弁であって、
前記人工弁が、開放状態と閉鎖状態との間を移動できる複数のリーフレットを含み、各リーフレットが、複合材料を含み、前記複合材料が、複数の細孔を有する少なくとも1つのフルオロポリマー層と、前記少なくとも1つのフルオロポリマー層の前記細孔の実質的にすべてを満たすエラストマー又はエラストマー材料とを有し、前記エラストマー又はエラストマー材料がTFE/PMVEコポリマーであることを特徴とする、人工弁。 - ヒト患者の血流方向を調節するための埋め込み可能な心臓弁であって、
前記埋め込み可能な心臓弁が、血流が前記埋め込み可能な心臓弁を通過することを可能とする第1の配置と、血流が前記埋め込み可能な心臓弁を通過することを阻止する第2の配置との間を循環可能な複数のリーフレットを備えており、
各リーフレットが、複数の細孔を有する少なくとも1つのフルオロポリマー層と、前記少なくとも1つのフルオロポリマー層の細孔の実質的にすべてに存在するエラストマー又はエラストマー材料とを有する複合材料を含んでおり、そして
前記複合材料が、55重量%未満のフルオロポリマーを含み、120μm未満の厚みを有し、前記エラストマー又はエラストマー材料がTFE/PMVEコポリマーである、前記埋め込み可能な心臓弁。 - 前記埋め込み可能な心臓弁を横断するEOAが、4千万回のサイクルの後、10%未満に維持される、請求項26に記載の埋め込み可能な心臓弁。
- 前記埋め込み可能な心臓弁を横断する逆流率が、4千万回のサイクルの後、15%未満に維持される、請求項26に記載の埋め込み可能な心臓弁。
- 4千万回のサイクルの後、前記リーフレットに端部剥離または孔形成が生じない、請求項26に記載の埋め込み可能な心臓弁。
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/078,774 US8961599B2 (en) | 2011-04-01 | 2011-04-01 | Durable high strength polymer composite suitable for implant and articles produced therefrom |
US13/078,774 | 2011-04-01 |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016230107A Division JP6426680B2 (ja) | 2011-04-01 | 2016-11-28 | インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2019000669A JP2019000669A (ja) | 2019-01-10 |
JP6725601B2 true JP6725601B2 (ja) | 2020-07-22 |
Family
ID=46928248
Family Applications (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014502831A Expired - Fee Related JP6051202B2 (ja) | 2011-04-01 | 2012-03-30 | インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 |
JP2016230107A Expired - Fee Related JP6426680B2 (ja) | 2011-04-01 | 2016-11-28 | インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 |
JP2018153634A Expired - Fee Related JP6725601B2 (ja) | 2011-04-01 | 2018-08-17 | インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 |
Family Applications Before (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2014502831A Expired - Fee Related JP6051202B2 (ja) | 2011-04-01 | 2012-03-30 | インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 |
JP2016230107A Expired - Fee Related JP6426680B2 (ja) | 2011-04-01 | 2016-11-28 | インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 |
Country Status (12)
Country | Link |
---|---|
US (3) | US8961599B2 (ja) |
EP (2) | EP2694123B1 (ja) |
JP (3) | JP6051202B2 (ja) |
KR (2) | KR101994463B1 (ja) |
CN (2) | CN103458934B (ja) |
AU (1) | AU2012236318B2 (ja) |
BR (1) | BR112013025114A2 (ja) |
CA (2) | CA2830355C (ja) |
ES (1) | ES2663094T3 (ja) |
HK (1) | HK1254143A1 (ja) |
RU (1) | RU2013148783A (ja) |
WO (1) | WO2012135603A2 (ja) |
Families Citing this family (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2008260444B2 (en) * | 2007-06-04 | 2014-09-11 | St. Jude Medical, Inc. | Prosthetic heart valves |
PT3653173T (pt) * | 2008-06-06 | 2021-07-12 | Edwards Lifesciences Corp | Válvula cardíaca transcateter de baixo perfil |
US8579964B2 (en) | 2010-05-05 | 2013-11-12 | Neovasc Inc. | Transcatheter mitral valve prosthesis |
US9744033B2 (en) | 2011-04-01 | 2017-08-29 | W.L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
US9801712B2 (en) | 2011-04-01 | 2017-10-31 | W. L. Gore & Associates, Inc. | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
US8961599B2 (en) | 2011-04-01 | 2015-02-24 | W. L. Gore & Associates, Inc. | Durable high strength polymer composite suitable for implant and articles produced therefrom |
US8945212B2 (en) * | 2011-04-01 | 2015-02-03 | W. L. Gore & Associates, Inc. | Durable multi-layer high strength polymer composite suitable for implant and articles produced therefrom |
US20130197631A1 (en) | 2011-04-01 | 2013-08-01 | W. L. Gore & Associates, Inc. | Durable multi-layer high strength polymer composite suitable for implant and articles produced therefrom |
US9554900B2 (en) * | 2011-04-01 | 2017-01-31 | W. L. Gore & Associates, Inc. | Durable high strength polymer composites suitable for implant and articles produced therefrom |
US9308087B2 (en) | 2011-04-28 | 2016-04-12 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
US9554897B2 (en) | 2011-04-28 | 2017-01-31 | Neovasc Tiara Inc. | Methods and apparatus for engaging a valve prosthesis with tissue |
US9554806B2 (en) | 2011-09-16 | 2017-01-31 | W. L. Gore & Associates, Inc. | Occlusive devices |
US9539360B2 (en) * | 2011-10-07 | 2017-01-10 | W. L. Gore & Associaes, Inc. | Puncturable and resealable graft |
DE102011117892A1 (de) * | 2011-10-31 | 2013-05-02 | Berlin Heart Gmbh | Verbindungselement zum Montieren einer Blutpumpe oder einer Kanüle an einem Herzen |
US9345573B2 (en) | 2012-05-30 | 2016-05-24 | Neovasc Tiara Inc. | Methods and apparatus for loading a prosthesis onto a delivery system |
US9283072B2 (en) | 2012-07-25 | 2016-03-15 | W. L. Gore & Associates, Inc. | Everting transcatheter valve and methods |
US10376360B2 (en) | 2012-07-27 | 2019-08-13 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic valve apparatus and methods |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
US9737398B2 (en) | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
US9398952B2 (en) | 2012-12-19 | 2016-07-26 | W. L. Gore & Associates, Inc. | Planar zone in prosthetic heart valve leaflet |
US10966820B2 (en) | 2012-12-19 | 2021-04-06 | W. L. Gore & Associates, Inc. | Geometric control of bending character in prosthetic heart valve leaflets |
US10321986B2 (en) | 2012-12-19 | 2019-06-18 | W. L. Gore & Associates, Inc. | Multi-frame prosthetic heart valve |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US9968443B2 (en) | 2012-12-19 | 2018-05-15 | W. L. Gore & Associates, Inc. | Vertical coaptation zone in a planar portion of prosthetic heart valve leaflet |
US10039638B2 (en) | 2012-12-19 | 2018-08-07 | W. L. Gore & Associates, Inc. | Geometric prosthetic heart valves |
EP2968675A1 (en) * | 2013-03-13 | 2016-01-20 | W. L. Gore & Associates, Inc. | Durable multi-layer high strength polymer composite suitable for implant and articles produced therefrom |
CA2900656C (en) * | 2013-03-13 | 2021-05-11 | W. L. Gore & Associates, Inc. | Durable high strength polymer composites suitable for implant and articles produced therefrom |
CA2900805C (en) * | 2013-03-13 | 2019-08-13 | W.L. Gore & Associates, Inc. | Elastomeric leaflet for prosthetic heart valves |
US9681951B2 (en) | 2013-03-14 | 2017-06-20 | Edwards Lifesciences Cardiaq Llc | Prosthesis with outer skirt and anchors |
US9572665B2 (en) | 2013-04-04 | 2017-02-21 | Neovasc Tiara Inc. | Methods and apparatus for delivering a prosthetic valve to a beating heart |
US11911258B2 (en) | 2013-06-26 | 2024-02-27 | W. L. Gore & Associates, Inc. | Space filling devices |
US9504565B2 (en) * | 2013-12-06 | 2016-11-29 | W. L. Gore & Associates, Inc. | Asymmetric opening and closing prosthetic valve leaflet |
EP3182929B1 (en) | 2014-08-18 | 2023-08-09 | Edwards Lifesciences Corporation | Frame with integral sewing cuff for prosthetic valves |
US9827094B2 (en) | 2014-09-15 | 2017-11-28 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with retention elements |
US10507101B2 (en) * | 2014-10-13 | 2019-12-17 | W. L. Gore & Associates, Inc. | Valved conduit |
US9937037B2 (en) | 2014-12-18 | 2018-04-10 | W. L. Gore & Associates, Inc. | Prosthetic valved conduits with mechanically coupled leaflets |
CA2973346C (en) * | 2015-02-13 | 2021-07-20 | W.L. Gore & Associates, Inc. | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
US10232564B2 (en) * | 2015-04-29 | 2019-03-19 | Edwards Lifesciences Corporation | Laminated sealing member for prosthetic heart valve |
JP2018515246A (ja) | 2015-05-14 | 2018-06-14 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティドW.L. Gore & Associates, Incorporated | 心耳の閉塞のためのデバイスおよび方法 |
US10022223B2 (en) | 2015-10-06 | 2018-07-17 | W. L. Gore & Associates, Inc. | Leaflet support devices and methods of making and using the same |
CN108601645B (zh) | 2015-12-15 | 2021-02-26 | 内奥瓦斯克迪亚拉公司 | 经中隔递送系统 |
US9968447B2 (en) * | 2016-01-22 | 2018-05-15 | Medtronic Vascular, Inc. | Bioprosthetic tissue for use as a prosthetic valve leaflet and method of preparing |
EP4183372A1 (en) | 2016-01-29 | 2023-05-24 | Neovasc Tiara Inc. | Prosthetic valve for avoiding obstruction of outflow |
EP3541462A4 (en) | 2016-11-21 | 2020-06-17 | Neovasc Tiara Inc. | METHODS AND SYSTEMS FOR RAPID RETRACTION OF A TRANSCATHETER HEART VALVE DELIVERY SYSTEM |
US11406533B2 (en) | 2017-03-17 | 2022-08-09 | W. L. Gore & Associates, Inc. | Integrated aqueous shunt for glaucoma treatment |
US10952842B2 (en) | 2017-06-07 | 2021-03-23 | W. L. Gore & Associates, Inc. | Prosthetic valve with improved washout |
US11224509B2 (en) | 2017-06-30 | 2022-01-18 | Ohio State Innovation Foundation | Prosthetic heart valve with tri-leaflet design for use in percutaneous valve replacement procedures |
US10856984B2 (en) | 2017-08-25 | 2020-12-08 | Neovasc Tiara Inc. | Sequentially deployed transcatheter mitral valve prosthesis |
AU2018334191B2 (en) | 2017-09-12 | 2021-04-08 | Edwards Lifesciences Corporation | Leaflet frame attachment for prosthetic valves |
CN115024861A (zh) | 2017-09-27 | 2022-09-09 | W.L.戈尔及同仁股份有限公司 | 具有机械联接的瓣叶的假体瓣膜 |
CA3072814C (en) | 2017-09-27 | 2023-01-03 | W.L. Gore & Associates, Inc. | Prosthetic valve with expandable frame and associated systems and methods |
CN111447890B (zh) | 2017-10-13 | 2023-01-31 | W.L.戈尔及同仁股份有限公司 | 叠套式假体瓣膜及递送系统 |
US11173023B2 (en) | 2017-10-16 | 2021-11-16 | W. L. Gore & Associates, Inc. | Medical devices and anchors therefor |
EP3703615B1 (en) | 2017-10-31 | 2024-05-15 | W. L. Gore & Associates, Inc. | Transcatheter deployment systems and associated methods |
AU2018362080B2 (en) | 2017-10-31 | 2021-09-30 | Edwards Lifesciences Corporation | Valved conduit |
CN111315419A (zh) * | 2017-10-31 | 2020-06-19 | W.L.戈尔及同仁股份有限公司 | 合成假体瓣膜瓣叶 |
US11123183B2 (en) | 2017-10-31 | 2021-09-21 | W. L. Gore & Associates, Inc. | Prosthetic heart valve |
US11154397B2 (en) | 2017-10-31 | 2021-10-26 | W. L. Gore & Associates, Inc. | Jacket for surgical heart valve |
JP7052032B2 (ja) | 2017-10-31 | 2022-04-11 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | 組織内方成長を促進する医療用弁及び弁膜 |
US11166811B2 (en) | 2018-03-02 | 2021-11-09 | James Yashu Coe | Transcatheter valve |
US20210259831A1 (en) | 2018-06-20 | 2021-08-26 | W. L. Gore & Associates, Inc. | Support structure for an implantable device with enhanced compressive stiffness region(s) |
CN109293961B (zh) * | 2018-09-25 | 2021-08-13 | 湖南博隽生物医药有限公司 | 一种心脏瓣膜用聚合物材料及其制备方法 |
USD977642S1 (en) | 2018-10-29 | 2023-02-07 | W. L. Gore & Associates, Inc. | Pulmonary valve conduit |
USD926322S1 (en) | 2018-11-07 | 2021-07-27 | W. L. Gore & Associates, Inc. | Heart valve cover |
AU2019374743B2 (en) | 2018-11-08 | 2022-03-03 | Neovasc Tiara Inc. | Ventricular deployment of a transcatheter mitral valve prosthesis |
US11678983B2 (en) | 2018-12-12 | 2023-06-20 | W. L. Gore & Associates, Inc. | Implantable component with socket |
EP3905990A4 (en) * | 2019-01-03 | 2022-08-31 | Renovo Medsolutions, LLC | VENOUS VALVE PROSTHESIS |
US11497601B2 (en) | 2019-03-01 | 2022-11-15 | W. L. Gore & Associates, Inc. | Telescoping prosthetic valve with retention element |
CA3132873A1 (en) | 2019-03-08 | 2020-09-17 | Neovasc Tiara Inc. | Retrievable prosthesis delivery system |
CN113811265A (zh) | 2019-04-01 | 2021-12-17 | 内奥瓦斯克迪亚拉公司 | 能够以可控的方式部署的假体瓣膜 |
AU2020271896B2 (en) | 2019-04-10 | 2022-10-13 | Neovasc Tiara Inc. | Prosthetic valve with natural blood flow |
WO2020236931A1 (en) | 2019-05-20 | 2020-11-26 | Neovasc Tiara Inc. | Introducer with hemostasis mechanism |
WO2020257643A1 (en) | 2019-06-20 | 2020-12-24 | Neovasc Tiara Inc. | Low profile prosthetic mitral valve |
JP2022543074A (ja) | 2019-08-01 | 2022-10-07 | ダブリュ.エル.ゴア アンド アソシエイツ,インコーポレイティド | 多部品フレームサブコンポーネントの横方向変形抵抗を備えた経カテーテル人工弁 |
CN114206267A (zh) | 2019-08-08 | 2022-03-18 | W.L.戈尔及同仁股份有限公司 | 具有不对称瓣叶的假体瓣膜 |
CN116036366B (zh) * | 2020-01-16 | 2024-10-18 | 四川大学 | 一种人工心脏瓣膜 |
EP4225214A1 (en) * | 2020-10-07 | 2023-08-16 | St. Jude Medical, Cardiology Division, Inc. | Heat treating to improve synthetic leaflet motion and coaptation |
CN116251238B (zh) * | 2023-02-28 | 2023-11-21 | 上海心纪元医疗科技有限公司 | 具有三层结构的仿生瓣膜瓣叶及其制造方法 |
Family Cites Families (78)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE392582B (sv) | 1970-05-21 | 1977-04-04 | Gore & Ass | Forfarande vid framstellning av ett porost material, genom expandering och streckning av en tetrafluoretenpolymer framstelld i ett pastabildande strengsprutningsforfarande |
US4340091A (en) | 1975-05-07 | 1982-07-20 | Albany International Corp. | Elastomeric sheet materials for heart valve and other prosthetic implants |
US4339831A (en) | 1981-03-27 | 1982-07-20 | Medtronic, Inc. | Dynamic annulus heart valve and reconstruction ring |
US4629459A (en) | 1983-12-28 | 1986-12-16 | Shiley Inc. | Alternate stent covering for tissue valves |
US5071609A (en) | 1986-11-26 | 1991-12-10 | Baxter International Inc. | Process of manufacturing porous multi-expanded fluoropolymers |
US4806382A (en) * | 1987-04-10 | 1989-02-21 | University Of Florida | Ocular implants and methods for their manufacture |
US4816339A (en) | 1987-04-28 | 1989-03-28 | Baxter International Inc. | Multi-layered poly(tetrafluoroethylene)/elastomer materials useful for in vivo implantation |
US4955899A (en) | 1989-05-26 | 1990-09-11 | Impra, Inc. | Longitudinally compliant vascular graft |
WO1997024083A1 (en) * | 1993-11-01 | 1997-07-10 | Cox James L | Method of replacing heart valves using flexible tubes |
EP0705081B1 (en) | 1994-04-22 | 2001-10-17 | Medtronic, Inc. | Stented bioprosthetic heart valve |
DE69419265T2 (de) | 1994-07-27 | 2000-01-05 | W.L. Gore & Associates, Inc. | Höchfeste poröse folie aus ptfe |
DE69428056T2 (de) | 1994-09-02 | 2002-01-03 | W.L. Gore & Associates, Inc. | Poröse polytetrafluorethylen zusammensetzungen |
US6428571B1 (en) | 1996-01-22 | 2002-08-06 | Scimed Life Systems, Inc. | Self-sealing PTFE vascular graft and manufacturing methods |
EP2298241A3 (en) | 1996-12-03 | 2011-11-02 | Atrium Medical Corporation | Multi-stage prothesis |
US6451396B1 (en) | 1998-02-13 | 2002-09-17 | Gore Enterprise Holdings, Inc. | Flexure endurant composite elastomer compositions |
US7049380B1 (en) | 1999-01-19 | 2006-05-23 | Gore Enterprise Holdings, Inc. | Thermoplastic copolymer of tetrafluoroethylene and perfluoromethyl vinyl ether and medical devices employing the copolymer |
EP1185415B1 (en) | 1999-05-10 | 2003-07-02 | The Secretary Of State For Defence | Smart porous film or material |
US7628803B2 (en) | 2001-02-05 | 2009-12-08 | Cook Incorporated | Implantable vascular device |
US20030055492A1 (en) | 1999-08-20 | 2003-03-20 | Shaolian Samuel M. | Transluminally implantable venous valve |
US6440164B1 (en) | 1999-10-21 | 2002-08-27 | Scimed Life Systems, Inc. | Implantable prosthetic valve |
US6652583B2 (en) | 2000-04-07 | 2003-11-25 | Rhode Island Hospital | Cardiac valve replacement |
US7374571B2 (en) | 2001-03-23 | 2008-05-20 | Edwards Lifesciences Corporation | Rolled minimally-invasive heart valves and methods of manufacture |
US6761733B2 (en) | 2001-04-11 | 2004-07-13 | Trivascular, Inc. | Delivery system and method for bifurcated endovascular graft |
CA2450160C (en) | 2001-06-11 | 2011-03-22 | Boston Scientific Limited | Composite eptfe/textile prosthesis |
US6541589B1 (en) | 2001-10-15 | 2003-04-01 | Gore Enterprise Holdings, Inc. | Tetrafluoroethylene copolymer |
US6776604B1 (en) | 2001-12-20 | 2004-08-17 | Trivascular, Inc. | Method and apparatus for shape forming endovascular graft material |
WO2003092554A1 (en) | 2002-05-03 | 2003-11-13 | The General Hospital Corporation | Involuted endovascular valve and method of construction |
US20030211264A1 (en) * | 2002-05-09 | 2003-11-13 | Farnsworth Ted Ray | Expanded polytetrafluoroethylene (ePTFE)-reinforced perfluoroelastomers (FFKM) |
EP1507492A1 (en) * | 2002-05-10 | 2005-02-23 | Cordis Corporation | Method of making a medical device having a thin wall tubular membrane over a structural frame |
US7351256B2 (en) | 2002-05-10 | 2008-04-01 | Cordis Corporation | Frame based unidirectional flow prosthetic implant |
US7789908B2 (en) * | 2002-06-25 | 2010-09-07 | Boston Scientific Scimed, Inc. | Elastomerically impregnated ePTFE to enhance stretch and recovery properties for vascular grafts and coverings |
US20040024448A1 (en) * | 2002-08-05 | 2004-02-05 | Chang James W. | Thermoplastic fluoropolymer-coated medical devices |
US7448122B1 (en) | 2003-10-31 | 2008-11-11 | Advanced Cardiovascular Systems, Inc. | Method of compressing a polymeric layer of an expandable medical device |
US7261732B2 (en) * | 2003-12-22 | 2007-08-28 | Henri Justino | Stent mounted valve |
US20110039690A1 (en) | 2004-02-02 | 2011-02-17 | Nanosys, Inc. | Porous substrates, articles, systems and compositions comprising nanofibers and methods of their use and production |
NZ551646A (en) | 2004-06-09 | 2010-11-26 | Pathogen Removal & Diagnostic Technologies Inc | Particles embedded in a porous substrate for removing target analyte from a sample |
GB0414099D0 (en) | 2004-06-23 | 2004-07-28 | Univ Glasgow | Biocompatible layered structures and methods for their manufacture |
EP1796693A2 (en) | 2004-08-26 | 2007-06-20 | Chandrashekhar P. Pathak | Implantable tissue compositions and method |
EP1807023A1 (en) | 2004-09-10 | 2007-07-18 | Cook Incorporated | Prosthetic valve with pores |
US8691543B2 (en) | 2009-11-25 | 2014-04-08 | Worcester Polytechnic Institute | Nanofibrous scaffold comprising immobilized cells |
CN101180010B (zh) * | 2005-05-24 | 2010-12-01 | 爱德华兹生命科学公司 | 快速展开假体心脏瓣膜 |
WO2007002320A1 (en) | 2005-06-27 | 2007-01-04 | The Cleveland Clinic Foundation | Apparatus for placement in the annulus of a tricuspid valve |
US7531611B2 (en) | 2005-07-05 | 2009-05-12 | Gore Enterprise Holdings, Inc. | Copolymers of tetrafluoroethylene |
CN101242889A (zh) * | 2005-07-18 | 2008-08-13 | 戈尔企业控股股份有限公司 | 多孔ptfe材料以及由其生产的制品 |
US7306729B2 (en) | 2005-07-18 | 2007-12-11 | Gore Enterprise Holdings, Inc. | Porous PTFE materials and articles produced therefrom |
WO2007016251A2 (en) | 2005-07-28 | 2007-02-08 | Cook Incorporated | Implantable thromboresistant valve |
US20070118210A1 (en) | 2005-11-18 | 2007-05-24 | Leonard Pinchuk | Trileaflet Heart Valve |
EP3400908B1 (en) * | 2006-05-30 | 2020-06-17 | Cook Medical Technologies LLC | Artificial valve prosthesis |
KR20090054427A (ko) * | 2006-07-07 | 2009-05-29 | 안토니오 누에즈 | 관내 인공 삽입 임플란트를 모니터링하기 위한 방법 및 시스템 |
US20080125711A1 (en) | 2006-08-07 | 2008-05-29 | Alpini Alfred A | Catheter balloons with integrated non-distensible seals |
WO2008046092A2 (en) | 2006-10-13 | 2008-04-17 | Creighton University | Implantable valve prosthesis |
US20080220054A1 (en) | 2006-10-13 | 2008-09-11 | Shastri V Prasad | Modulation of drug release rate from electrospun fibers |
WO2008069759A1 (en) | 2006-12-05 | 2008-06-12 | Nanyang Technological University | Manufacturing three-dimensional scaffolds using electrospinning at low temperatures |
US8932619B2 (en) | 2007-06-27 | 2015-01-13 | Sofradim Production | Dural repair material |
US20090187197A1 (en) | 2007-08-03 | 2009-07-23 | Roeber Peter J | Knit PTFE Articles and Mesh |
WO2009038761A1 (en) | 2007-09-19 | 2009-03-26 | St. Jude Medical, Inc. | Fiber-reinforced synthetic sheets for prosthetic heart valve leaflets |
US8637144B2 (en) | 2007-10-04 | 2014-01-28 | W. L. Gore & Associates, Inc. | Expandable TFE copolymers, method of making, and porous, expended articles thereof |
US9402724B2 (en) | 2008-05-12 | 2016-08-02 | Mo-Sci Corporation | Dynamic bioactive nanofiber scaffolding |
PT3653173T (pt) | 2008-06-06 | 2021-07-12 | Edwards Lifesciences Corp | Válvula cardíaca transcateter de baixo perfil |
US20150265744A1 (en) | 2008-10-09 | 2015-09-24 | Technische Universiteit Eindhoven | Multilayer preform obtained by electro-spinning, method for producing a preform as well as use thereof |
NL1036038C (en) | 2008-10-09 | 2010-04-14 | Univ Eindhoven Tech | Multilayer preform obtained by electro-spinning, method for producing a preform as well as use thereof. |
US20160067374A1 (en) | 2009-01-16 | 2016-03-10 | Zeus Industrial Products, Inc. | Composite prosthetic devices |
US9139669B2 (en) | 2009-03-24 | 2015-09-22 | W. L. Gore & Associates, Inc. | Expandable functional TFE copolymer fine powder, the expandable functional products obtained therefrom and reaction of the expanded products |
US9457322B2 (en) | 2009-04-13 | 2016-10-04 | Entegris, Inc. | Porous composite membrane |
US10022222B2 (en) | 2009-10-06 | 2018-07-17 | Adam Groothuis | Systems and methods for treating lumenal valves |
MX339572B (es) | 2009-11-27 | 2016-05-18 | Univ Nac Autónoma De México | Materiales compuestos de matriz polimerica con reforzantes de diferentes morfologias y sus procedimientos de sintesis. |
US8795354B2 (en) * | 2010-03-05 | 2014-08-05 | Edwards Lifesciences Corporation | Low-profile heart valve and delivery system |
ES2727409T3 (es) | 2010-03-11 | 2019-10-16 | Univ Texas | Sistema de andamiaje para reparar problemas cardiovasculares |
US9066997B2 (en) | 2010-06-02 | 2015-06-30 | The Regents Of The University Of Michigan | Scaffolds and methods of forming the same |
US8961599B2 (en) | 2011-04-01 | 2015-02-24 | W. L. Gore & Associates, Inc. | Durable high strength polymer composite suitable for implant and articles produced therefrom |
US9801712B2 (en) | 2011-04-01 | 2017-10-31 | W. L. Gore & Associates, Inc. | Coherent single layer high strength synthetic polymer composites for prosthetic valves |
US8945212B2 (en) | 2011-04-01 | 2015-02-03 | W. L. Gore & Associates, Inc. | Durable multi-layer high strength polymer composite suitable for implant and articles produced therefrom |
EP2522308B1 (de) | 2011-05-10 | 2015-02-25 | Biotronik AG | Mechanische Transkatheter-Herzklappenprothese |
US8945209B2 (en) | 2011-05-20 | 2015-02-03 | Edwards Lifesciences Corporation | Encapsulated heart valve |
CA2855943C (en) | 2011-07-29 | 2019-10-29 | Carnegie Mellon University | Artificial valved conduits for cardiac reconstructive procedures and methods for their production |
US9101469B2 (en) | 2012-12-19 | 2015-08-11 | W. L. Gore & Associates, Inc. | Prosthetic heart valve with leaflet shelving |
US9737398B2 (en) | 2012-12-19 | 2017-08-22 | W. L. Gore & Associates, Inc. | Prosthetic valves, frames and leaflets and methods thereof |
US9144492B2 (en) | 2012-12-19 | 2015-09-29 | W. L. Gore & Associates, Inc. | Truncated leaflet for prosthetic heart valves, preformed valve |
-
2011
- 2011-04-01 US US13/078,774 patent/US8961599B2/en not_active Expired - Fee Related
-
2012
- 2012-03-30 BR BR112013025114-0A patent/BR112013025114A2/pt not_active Application Discontinuation
- 2012-03-30 WO PCT/US2012/031417 patent/WO2012135603A2/en active Application Filing
- 2012-03-30 RU RU2013148783/14A patent/RU2013148783A/ru not_active Application Discontinuation
- 2012-03-30 CN CN201280016600.6A patent/CN103458934B/zh not_active Expired - Fee Related
- 2012-03-30 EP EP12764638.8A patent/EP2694123B1/en not_active Not-in-force
- 2012-03-30 KR KR1020137027469A patent/KR101994463B1/ko active IP Right Grant
- 2012-03-30 CA CA2830355A patent/CA2830355C/en not_active Expired - Fee Related
- 2012-03-30 CA CA3039324A patent/CA3039324A1/en not_active Abandoned
- 2012-03-30 EP EP18150364.0A patent/EP3323439A1/en not_active Withdrawn
- 2012-03-30 ES ES12764638.8T patent/ES2663094T3/es active Active
- 2012-03-30 KR KR1020197018244A patent/KR102100082B1/ko active IP Right Grant
- 2012-03-30 JP JP2014502831A patent/JP6051202B2/ja not_active Expired - Fee Related
- 2012-03-30 AU AU2012236318A patent/AU2012236318B2/en not_active Ceased
- 2012-03-30 CN CN201710014101.8A patent/CN106668949B/zh not_active Expired - Fee Related
-
2015
- 2015-01-16 US US14/598,587 patent/US9770327B2/en active Active
- 2015-05-28 US US14/724,640 patent/US9795475B2/en active Active
-
2016
- 2016-11-28 JP JP2016230107A patent/JP6426680B2/ja not_active Expired - Fee Related
-
2018
- 2018-08-17 JP JP2018153634A patent/JP6725601B2/ja not_active Expired - Fee Related
- 2018-10-16 HK HK18113214.3A patent/HK1254143A1/zh unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP6725601B2 (ja) | インプラントに適した耐久性のある高強度ポリマー複合体及び該ポリマー複合体から製造された物品 | |
JP6826093B2 (ja) | インプラントに適した耐久性のある高強度のポリマー複合体及び該ポリマー複合体から製造された物品 | |
JP5785326B2 (ja) | インプラントに適した耐久性のある高強度多層ポリマー複合体と、そのポリマー複合体から製造される製品 | |
JP2016514011A (ja) | インプラントに適した耐久性多層高強度ポリマー複合体及びそれから製造された物品 | |
AU2020204354A1 (en) | Durable high strength polymer composite suitable for implant and articles produced therefrom | |
AU2020201784A1 (en) | Durable multi-layer high strength polymer composite suitable for implant and articles produced therefrom |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20180918 |
|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20180918 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20190820 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20191119 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200219 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20200526 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20200625 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6725601 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
LAPS | Cancellation because of no payment of annual fees |